FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Liraglutide Injection

  • U.S. Food and Drug Administration
  • August 25, 2026
  • ID: shortage-liraglutide-injection-novo-nordisk-inc-0480-3667-22

Drug Shortage Details

Generic NameLiraglutide Injection
Manufacturer / CompanyNovo Nordisk, Inc.
Therapeutic CategoryEndocrinology/Metabolism
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0480-3667-22
Presentation & Dosage Form

Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)

Manufacturer Contact Info

833-493-4689

Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.
View Official Announcement on FDA.gov

Recent FDA Updates

Drug Shortage
FDA Drug Shortage: Pentostatin Injection
Aug 27, 2026
FDA Safety Alert
Early Alert: Esophageal pH Monitoring Capsule Delivery Devic...
Aug 27, 2026
FDA Safety Alert
Convenience Kit Correction: AVID Medical Issues Correction f...
Aug 27, 2026
Back to FDA Media Center